CEO & CFO Moves Review – November 8, 2024

by BA Research | Nov 11, 2024 | CEO / CFO / Director Resignations & Appointments, Featured, Latest Research

Weekly CEO & CFO Moves Update Last week’s CEO and CFO changes at public companies highlighted specific challenges facing each organization and the new leaders stepping in. At Adial Pharmaceuticals (ADIL), which has seen a -52.9% one-year total shareholder return...

Daily SPAC Update – November 11, 2024

by BA Research | Nov 11, 2024 | SPACs

CLOE + Global Hydrogen Energy Deal Termination / Liquidation. ASPC and WLAC SPAC IPOs. DPCS Extension Vote. RENE Extension and ACAB Deal Approved.  Boardroom Alpha SPAC Resources – Full SPAC Listing – SPAC SEC Filings – Boardroom Alpha IPO & SPAC...

Daily SPAC Update – November 8, 2024

by BA Research | Nov 8, 2024 | SPACs

CLOE + Global Hydrogen Energy Deal Vote. $200M GSR III Acquisition SPAC IPO. ACAB Deal Approved. NPAB and CCTS Shareholders Approve Extension.  Boardroom Alpha SPAC Resources – Full SPAC Listing – SPAC SEC Filings – Boardroom Alpha IPO & SPAC...

Daily SPAC Update – November 7, 2024

by BA Research | Nov 7, 2024 | SPACs

ACAB + Abpro SPAC Deal Vote. MCAA Extension Vote. FRLA and INTE Shareholders Extend. ROCL Deal and GLAC Extension Votes Set. ACAB Non-Redemption Agreement.  Boardroom Alpha SPAC Resources – Full SPAC Listing – SPAC SEC Filings – Boardroom Alpha IPO...

Daily SPAC Update – November 6, 2024

by BA Research | Nov 6, 2024 | SPACs

NRAC and ALCY Shareholders Approve SPAC Extensions. YHNA Separate Trading. ESHA Extension Vote on Dec 3. FNVT and RENE Extension Votes Today.  Boardroom Alpha SPAC Resources – Full SPAC Listing – SPAC SEC Filings – Boardroom Alpha IPO & SPAC...